H.C. Wainwright Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $16

Futu NewsJan 10 23:31 · Ratings

Solid Biosciences' Innovative Gene Therapy SGT-212 Gains Buy Rating Amid Promising Preclinical Results and FDA Approval

TipRanksJan 10 23:25 · Ratings

Piper Sandler Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $20

Futu NewsJan 10 20:34 · Ratings

12 Health Care Stocks Moving In Friday's Pre-Market Session

BenzingaJan 10 20:05

Solid Biosciences (SLDB) Receives a Buy From Piper Sandler

TipRanksJan 10 19:46 · Ratings

Barclays Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $15

Futu NewsJan 9 17:34 · Ratings